Cary J. Claiborne
2023 - ADIAL PHARMACEUTICALS
In 2023, Cary J. Claiborne earned a total compensation of $801.6K as Chief Executive Officer and Member of the Board of Directors at ADIAL PHARMACEUTICALS, a 21% decrease compared to previous year.
Compensation breakdown
Bonus | $190,000 |
---|---|
Option Awards | $73,314 |
Salary | $465,625 |
Other | $72,682 |
Total | $801,621 |
Claiborne received $465.6K in salary, accounting for 58% of the total pay in 2023.
Claiborne also received $190K in bonus, $73.3K in option awards and $72.7K in other compensation.
Rankings
In 2023, Cary J. Claiborne's compensation ranked 1,375th out of 2,647 executives tracked by ExecPay. In other words, Claiborne earned more than 48.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,375 | 48th |
Manufacturing | 819 | 43rd |
Chemicals And Allied Products | 531 | 35th |
Drugs | 515 | 34th |
Pharmaceutical Preparations | 356 | 36th |
Claiborne's colleagues
We found two more compensation records of executives who worked with Cary J. Claiborne at ADIAL PHARMACEUTICALS in 2023.